• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High Variability on Alcohol Intake Threshold in Articles Using the MAFLD Acronym.

作者信息

Hernandez-Tejero Maria, Ravi Samhita, Behari Jaideep, Arteel Gavin E, Arab Juan Pablo, Bataller Ramon

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Center for Liver Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

出版信息

Gastro Hep Adv. 2023 Sep 3;3(1):96-100. doi: 10.1016/j.gastha.2023.08.016. eCollection 2024.

DOI:10.1016/j.gastha.2023.08.016
PMID:39132176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308239/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8445/11308239/748f52f8bd89/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8445/11308239/abf9854d091d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8445/11308239/748f52f8bd89/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8445/11308239/abf9854d091d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8445/11308239/748f52f8bd89/gr2.jpg

相似文献

1
High Variability on Alcohol Intake Threshold in Articles Using the MAFLD Acronym.使用MAFLD首字母缩写的文章中酒精摄入阈值的高度变异性。
Gastro Hep Adv. 2023 Sep 3;3(1):96-100. doi: 10.1016/j.gastha.2023.08.016. eCollection 2024.
2
Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?非酒精性脂肪性肝病患者的有害饮酒是否会导致不同的饮食摄入？
Nutrients. 2022 Mar 23;14(7):1335. doi: 10.3390/nu14071335.
3
Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.饮酒对代谢相关脂肪性肝病发生和缓解的影响：一项纵向队列研究。
Eur J Clin Invest. 2024 Sep;54(9):e14221. doi: 10.1111/eci.14221. Epub 2024 Apr 18.
4
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.与非酒精性脂肪性肝病（NAFLD）相比，代谢功能障碍相关脂肪性肝病（MAFLD）能更好地识别出有显著肝纤维化的患者。
Liver Int. 2020 Dec;40(12):3018-3030. doi: 10.1111/liv.14675.
5
Metabolic dysfunction-associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients.代谢功能障碍相关脂肪性肝病与病态肥胖患者的肝纤维化直接相关，独立于胰岛素抵抗、高脂血症和酒精摄入。
Hepatol Res. 2022 Oct;52(10):841-858. doi: 10.1111/hepr.13808. Epub 2022 Aug 6.
6
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.饮酒与代谢相关脂肪性肝病（MAFLD）对进展性脂肪性肝病的双向影响。
Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.
7
Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.代谢功能障碍相关脂肪性肝病和过量饮酒均为死亡的独立危险因素。
Hepatology. 2023 Mar 1;77(3):942-948. doi: 10.1002/hep.32642. Epub 2023 Feb 17.
8
Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study.酒精对新发生的代谢功能障碍相关脂肪性肝病在两性中影响的：一项纵向研究。
Clin Nutr. 2023 May;42(5):810-816. doi: 10.1016/j.clnu.2023.03.020. Epub 2023 Mar 31.
9
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease.男性和女性代谢功能障碍相关脂肪性肝病患者的最低酒精摄入量不同。
Liver Int. 2024 Mar;44(3):865-875. doi: 10.1111/liv.15849. Epub 2024 Jan 23.
10
The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting.VA 初级保健环境中 NAFLD 和 MAFLD 的流行率及决定因素及其严重程度。
Clin Gastroenterol Hepatol. 2023 May;21(5):1252-1260.e5. doi: 10.1016/j.cgh.2022.05.046. Epub 2022 Jul 8.

本文引用的文献

1
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
2
Alcohol-Associated Hepatitis.酒精性肝炎
N Engl J Med. 2022 Dec 29;387(26):2436-2448. doi: 10.1056/NEJMra2207599.
3
New terms for fatty liver disease other than MAFLD: Time for a reality check.除代谢相关脂肪性肝病外的脂肪肝疾病新术语：是时候进行现实核查了。
J Hepatol. 2022 Dec;77(6):1716-1717. doi: 10.1016/j.jhep.2022.08.009. Epub 2022 Aug 18.
4
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.头发中的乙基葡糖苷检测到疑似非酒精性脂肪性肝病患者中有很高的有害饮酒率。
J Hepatol. 2022 Oct;77(4):918-930. doi: 10.1016/j.jhep.2022.04.040. Epub 2022 May 20.
5
Global multi-stakeholder endorsement of the MAFLD definition.全球多方利益相关者对MAFLD定义的认可。
Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3.
6
The NAFLD-MAFLD debate: Is there a Consensus-on-Consensus methodology?NAFLD-MAFLD 之争：是否存在共识中的共识方法学？
Liver Int. 2022 Apr;42(4):742-748. doi: 10.1111/liv.15197. Epub 2022 Feb 24.
7
Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?将非酒精性脂肪性肝病重新定义为代谢相关脂肪性肝病：这合理吗？
World J Hepatol. 2022 Jan 27;14(1):158-167. doi: 10.4254/wjh.v14.i1.158.
8
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.遗传风险评分和糖尿病可预测饮酒者发生酒精性肝硬化。
J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14.
9
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.中华医学会肝病学分会关于脂肪肝疾病重新定义的立场声明。
J Hepatol. 2021 Aug;75(2):454-461. doi: 10.1016/j.jhep.2021.05.003. Epub 2021 May 19.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.